BBNXBeta Bionics, Inc.
$17.44-21% 1Y
$17.44
$8.8652 weeks$31.99
The financials
Beta Bionics, Inc. by the numbers
Beta Bionics, Inc. (BBNX) reported revenue of $32M in Q2 2026 (quarter ended Jun 30, 2026), up 38% from the same quarter a year earlier. That came with a gross margin of 59% and net loss of $23M. For the full year FY2025, revenue was $100M (+54% year on year) and net income −$73M. The next results filing is expected around Oct 27, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $32M | $23M | +38% |
| Gross profit | $19M | $13M | +51% |
| Operating income | −$26M | −$20M | n/a |
| Net income | −$23M | −$17M | n/a |
| Diluted EPS | −$0.53 | −$0.39 | n/a |
Medical Devices
The closest names by size in the same industry